Breaking

Medication

1 stories

AllUNIQUEPHARMACEUTICALNOVONORDISKELILILLYAMGENFDAMERCKHEALTHPHARMACEUTICALSTGMCENVIRONMENT CANADAAKSTONPHARMACYTELANGANA DCAIMHDEAMHRAAMBLEPLASTICSURGERYAKSTON BIOSCIENCESTLCFFXNOWLIPFENDRAHSCPREP4ALLMEDSCAPEGSKFRACTYLHEALTHTRUMPRXTELEHEALTHGLENMARKMEDICAREEUROPEAN COMMISSIONHMSACVSCAR EMARKONCOLOGYKETABONPHARMACEUTICALLUPINLEQEMBIASCENSIONSAHPRAKENVUE
Anatomical illustration showing a cross-section of a human artery with cholesterol plaque buildup.
LIPFENDRA3d ago

A Novel Pill For Cholesterol: FDA Approves Lipfendra

The landscape of heart disease treatment shifted on July 16, 2026, when the FDA approved Lipfendra. This medication is the first oral PCSK9 inhibitor available to adults who struggle with persistently high LDL cholestero

← BACK TO ALL HEALTH NEWS